ANTI-PANCREATIC ISLET CELL ANTIBODY - ANVISA Registration 80102513388
Access comprehensive regulatory information for ANTI-PANCREATIC ISLET CELL ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102513388 and manufactured by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., MEDIPAN, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80102513388
25351022676202561
04718143000194
Company Information
Dates and Status
Mar 17, 2025
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTI-ILHOTA PANCREÁTICA
ICA IFA
GA GENERIC ASSAYS GMBH
80464810912
Sep 23, 2024
ANTICORPO ANTI-ILHOTA PANCREÁTICA
Família MAGLUMI ICA (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513057
Aug 07, 2023
ANTICORPO ANTI-ILHOTA PANCREÁTICA
ICA CONTROL
SHENZHEN YHLO BIOTECH CO., LTD.
80867150115
Jul 29, 2021
ANTICORPO ANTI-ILHOTA PANCREÁTICA
iFLASH – ICA
SHENZHEN YHLO BIOTECH CO., LTD.
80867150117
Jul 29, 2021
ANTICORPO ANTI-ILHOTA PANCREÁTICA
Medizym® anti-IA2 M
MEDIPAN
80464810725
Nov 05, 2020

